.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Citi
US Department of Justice
Merck
Harvard Business School
Chinese Patent Office
Dow
Boehringer Ingelheim
QuintilesIMS
Express Scripts

Generated: November 20, 2017

DrugPatentWatch Database Preview

RIMANTADINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Rimantadine Hydrochloride, and what generic Rimantadine Hydrochloride alternatives are available?

Rimantadine Hydrochloride is a drug marketed by Impax Labs Inc, Impax Labs, and Actavis Elizabeth. and is included in three NDAs.

The generic ingredient in RIMANTADINE HYDROCHLORIDE is rimantadine hydrochloride. There are three drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the rimantadine hydrochloride profile page.

Pharmacology for RIMANTADINE HYDROCHLORIDE

Medical Subject Heading (MeSH) Categories for RIMANTADINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Impax Labs Inc
RIMANTADINE HYDROCHLORIDE
rimantadine hydrochloride
TABLET;ORAL075916-001Nov 2, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe
Impax Labs
RIMANTADINE HYDROCHLORIDE
rimantadine hydrochloride
TABLET;ORAL076132-001Aug 30, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Elizabeth
RIMANTADINE HYDROCHLORIDE
rimantadine hydrochloride
TABLET;ORAL076375-001Jan 14, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
UBS
Federal Trade Commission
Medtronic
Johnson and Johnson
Covington
Argus Health
Cerilliant
Express Scripts
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot